Pex Gene Disruption for PUFA Yield in Oleaginous Yeast

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing large-scale quantities of polyunsaturated fatty acids (PUFAs) in organisms like Saccharomyces cerevisiae and other microbial systems face challenges in improving yield and controlling oil composition, as they rely on natural microbial abilities and lack effective optimization for commercial production.

Innovation Solution

Disrupting peroxisome biogenesis factor proteins in oleaginous eukaryotic organisms, such as Yarrowia lipolytica, to increase the weight percent of PUFAs by introducing genes encoding a functional PUFA biosynthetic pathway and disrupting native genes encoding peroxisome biogenesis factor proteins, thereby enhancing PUFA production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If peroxisome biogenesis factor proteins are disrupted in oleaginous eukaryotic organisms, then the weight percent of polyunsaturated fatty acids increases, but the complexity of genetic manipulation increases

Engineering Contradiction:
Improveweight percent of polyunsaturated fatty acidsVSAvoidcomplexity of genetic manipulation
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent extracts and removes peroxisome biogenesis factor proteins (Pex proteins) from the oleaginous eukaryotic organism through genetic disruption. By taking out these specific proteins that are responsible for peroxisome assembly and function, the patent redirects metabolic pathways to increase PUFA accumulation in the cytosol, thereby resolving the contradiction between increasing PUFA quantity and managing genetic manipulation complexity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the biological parameter of peroxisome biogenesis by disrupting Pex gene expression. This parameter change in protein synthesis leads to altered metabolic flux, redirecting fatty acid synthesis from peroxisomal beta-oxidation pathways to cytosolic PUFA accumulation, thus achieving increased PUFA weight percent through a fundamental biological parameter change.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If peroxisome biogenesis factor proteins are disrupted to increase PUFA production, then productivity improves, but manufacturing precision becomes more difficult to control

Engineering Contradiction:
ImprovePUFA production yieldVSAvoidcontrol of oil composition
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent implements a feedback mechanism where the disruption of Pex proteins creates a metabolic state that naturally favors PUFA accumulation. The altered metabolic flux serves as feedback that redirects carbon flow toward PUFA synthesis pathways, allowing the system to self-regulate and maintain high PUFA productivity while achieving consistent oil composition through the established metabolic rerouting.

Inventive Principle:
Principle #23Feedback

3Adaptability or versatility

If genes encoding PUFA biosynthetic pathway are introduced, then the functional capability for PUFA synthesis improves, but the device complexity increases

Engineering Contradiction:
Improvefunctional capability for PUFA synthesisVSAvoidgenetic pathway complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent merges the introduction of heterologous PUFA biosynthetic genes with the disruption of native Pex proteins in a coordinated genetic modification strategy. By combining these two genetic interventions, the patent creates a synergistic effect where the introduced PUFA pathway genes benefit from the metabolic rerouting caused by Pex disruption, achieving enhanced PUFA synthesis capability while managing overall genetic complexity through integrated design.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS9617571B2Peroxisome biogenesis factor protein (Pex) disruptions for altering polyunsaturated fatty acids and total lipid content in oleaginous eukaryotic organisms
Publication Date: 2017.04.11 DUPONT US HOLDING LLC
  • US9617571B2 patent drawing
  • US9617571B2 patent drawing
  • US9617571B2 patent drawing

AI summary

Methods of increasing the amount of polyunsaturated fatty acids (PUFAs) in the total lipid fraction and in the oil fraction of PUFA-producing, oleaginous eukaryotes, accomplished by modifying the activity of peroxisome biogenesis factor (Pex) proteins. Disruptions of a chromosomal Pex3 gene, Pex10p gene or Pex16p gene in a PUFA-producing, oleaginous eukaryotic strain resulted in an increased amount of PUFAs, as a percent of total fatty acids and as a percent of dry cell weight, in the total lipid fraction and in the oil fraction of the strain, as compared to the parental strain whose native Pex protein was not disrupted.